Advance Care Planning and Attainment of Cancer Patients' End-of-Life Preferences: Relatives' Perspective.

advance care planning advance directives discussion with family treatment preferences

Journal

The American journal of hospice & palliative care
ISSN: 1938-2715
Titre abrégé: Am J Hosp Palliat Care
Pays: United States
ID NLM: 9008229

Informations de publication

Date de publication:
Mar 2023
Historique:
pubmed: 20 5 2022
medline: 25 2 2023
entrez: 19 5 2022
Statut: ppublish

Résumé

The purpose of this study is to determine which element of advance care planning (ACP) - an advance directives (AD) document or an end-of-life discussion between patient and family (DwF), if any-improves the likelihood of cancer patients' attaining their preferences regarding treatments in the last month of life and dying in the place they prefer. First-degree relatives of deceased cancer patients, interviewed by telephone, were asked if the treatments the patients received in their last month of life and their place of death corresponded to the patients' preferences. Nominal logistic regression analyses were conducted in search of significant association between having an AD document and/or conducting a DwF and patients' treatment and place of death in accordance with their preferences. 491 deceased patients were included in the study. Their average age was 68; 52% were women. According to 32% of the relatives, the patients' treatment in the last month of life was aligned with their preferences and 55% said the patients had died in their preferred place. Only 16.5% had an AD document, 58.5% only discussed their treatment preferences with relatives, and 25% did neither. DwF and ability to speak until last week of life were significantly related to receiving treatment consistent with patients' preferences. Dying where the patient prefers is significantly associated with having an AD and a DwF, with an AD yielding higher odds. A multifaceted interconnection exists between the two elements of ACP in attaining cancer patients' wishes and abetting better end of life care.

Identifiants

pubmed: 35587799
doi: 10.1177/10499091221099921
pmc: PMC9941650
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

322-328

Références

CA Cancer J Clin. 2017 Jul 8;67(4):318-325
pubmed: 28319263
JAMA Intern Med. 2014 Jul;174(7):1085-92
pubmed: 24861560
J Clin Nurs. 2010 Jul;19(13-14):2023-31
pubmed: 20920028
Gerontologist. 2019 May 17;59(3):420-425
pubmed: 29045631
Am J Geriatr Psychiatry. 2016 Apr;24(4):261-71
pubmed: 26976293
Support Care Cancer. 2016 Oct;24(10):4131-40
pubmed: 27137213
N Engl J Med. 2002 Apr 4;346(14):1061-6
pubmed: 11932474
Patient Educ Couns. 2013 Apr;91(1):3-13
pubmed: 23332193
Lancet. 2003 Aug 2;362(9381):345-50
pubmed: 12907005
J Pain Symptom Manage. 2018 Sep;56(3):436-459.e25
pubmed: 29807158
JAMA Oncol. 2015 Aug;1(5):601-8
pubmed: 26181909
JAMA. 2021 Oct 26;326(16):1575-1576
pubmed: 34623373
J Clin Oncol. 2010 Mar 1;28(7):1203-8
pubmed: 20124172
BMC Palliat Care. 2013 Feb 15;12:7
pubmed: 23414145
J Clin Oncol. 2010 Oct 10;28(29):4457-64
pubmed: 20837950
Psychooncology. 2016 Apr;25(4):362-86
pubmed: 26387480
Am J Hosp Palliat Care. 2019 Oct;36(10):913-926
pubmed: 31072109
J Am Geriatr Soc. 2021 Jan;69(1):234-244
pubmed: 32894787
Lancet Oncol. 2017 Sep;18(9):e543-e551
pubmed: 28884703
Support Care Cancer. 2013 Feb;21(2):629-36
pubmed: 22933133
J Pain Symptom Manage. 2017 May;53(5):821-832.e1
pubmed: 28062339
Health Aff (Millwood). 2017 Jul 1;36(7):1244-1251
pubmed: 28679811
J Pain Symptom Manage. 2018 Feb;55(2):245-255.e8
pubmed: 28865870
J Am Med Dir Assoc. 2014 Jul;15(7):477-489
pubmed: 24598477
Palliat Med. 2014 Sep;28(8):1000-25
pubmed: 24651708
Am J Hosp Palliat Care. 2020 Dec;37(12):1045-1052
pubmed: 32281390
JAMA Intern Med. 2016 Aug 1;176(8):1095-102
pubmed: 27367547
Am J Hosp Palliat Care. 2019 Dec;36(12):1089-1095
pubmed: 31088134
J Pain Symptom Manage. 2015 Jun;49(6):1097-101
pubmed: 25637243
PLoS Med. 2020 Nov 13;17(11):e1003422
pubmed: 33186365
N Engl J Med. 2010 Apr 1;362(13):1211-8
pubmed: 20357283
J Cancer Educ. 2018 Oct;33(5):1140-1147
pubmed: 28456948
J Geriatr Oncol. 2021 Nov;12(8):1181-1185
pubmed: 34049836
Ann Intern Med. 2012 Feb 7;156(3):204-10
pubmed: 22312140
JAMA. 2004 Jan 7;291(1):88-93
pubmed: 14709580
N Engl J Med. 1994 Feb 24;330(8):540-4
pubmed: 8302321
J Pain Symptom Manage. 2015 Jun;49(6):1070-80
pubmed: 25623923
Psychooncology. 2013 Nov;22(11):2624-31
pubmed: 23893390
BMC Cancer. 2019 Jan 14;19(1):63
pubmed: 30642289
Bioethics. 2009 Mar;23(3):183-92
pubmed: 18410461
Arch Intern Med. 2006 Mar 13;166(5):493-7
pubmed: 16534034

Auteurs

Gil Bar-Sela (G)

Oncology and Hematology Division, 61172Emek Medical Center, Israel.

Aviad Tur-Sinai (A)

Department of Health Systems Management, 42724The Max Stern Yezreel Valley College, Jezreel Valley, Israel.
School of Nursing, University of Rochester Medical Center, New York.

Noa Givon-Schaham (N)

The Stanley Steyer School of Health Professions, 58408Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Netta Bentur (N)

The Stanley Steyer School of Health Professions, 58408Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH